Chronic nifedipine treatment diminishes cardiac inotropic response to nifedifine: Functional upregulation of dihydropyridine receptors

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 2, 1996, Pages 240-246

  Chiappe de Cingolani, Gladys E ^a   Mosca, Susana M ^a   Moreyra, Abel E ^a   Cingolani, Horacio E ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Calcium channels; Dihydropyridine receptors; Heart contractility; Nifedipine treatment

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT RECEPTOR; DIHYDROPYRIDINE DERIVATIVE; ISRADIPINE; NIFEDIPINE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBER MEMBRANE; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; RECEPTOR DENSITY; RECEPTOR UPREGULATION; REGIONAL PERFUSION;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; NIFEDIPINE; RABBITS; STIMULATION, CHEMICAL; UP-REGULATION;

EID: 9044242638     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199602000-00010     Document Type: Article

References (36)

1. Zusman RM. Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension. Am J Cardiol 1989;64:51F-61F.
2. Katz AM. Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implications. J Clin Pharmacol 1987;27:825-34.
3. Guazzi MD. Nitrendipine long-acting nifedipine in mild, moderate and severe hypertension. Angiology 1986;37:508-18.
4. Zusman RM. Left ventricular function in hypertension. Relevance to the selection of antihypertensive therapy. Am J Hypertens 1989;2:200S-6S.
5. Henry PD. Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazen. Am J Cardiol 1980;46:1047-58.
6. Hurtado MCC de, Rinaldi GJ, Mattiazzi AR, Cingolani HE. Los antagonistas cálcicos: Acciones farmacológicas cardiovasculares de la nifedipina. Medicina 1984;44:137-44.
7. 2+ channel antagonists and activators: a comparison of binding characteristics with pharmacology. Drug Dev Res 1984;4:257-74.
8. Gourgon R, Merillon JP, Guiomard A, Rural S. Effects of nifedipine on the load conditions and inotropism of the left ventricle in subjects suffering from nonocclusive primary cardiomyopathy. In: Puech P, Krebs R, eds. 4th International Adalat Symposium, Amsterdam; Excerpta Medica, 1980:268-74.
9. Polese A, Fiorentini C, Olivari MT, Guazi MD. Clinical use of calcium antagonist agent (nifedipine) in acute pulmonary edema. Am J Med 1979;66:825-30.
10. Stone PH, Antman EM, Muller JE, Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: hemodynamic effects and clinical applications. Ann Intern Med 1980;93:886-904.
11. Chapados RA, Gruver EJ, Ingwall JS, Marsh JD, Gwathmey JK. Chronic administration of cardiovascular drugs: altered energetics and transmembrane signaling. Am J Physiol 1992;263:H1576-86.
12. Chiappe de Cingolani GE, Mosca SM, Vila Petroff M, Cingolani HE. Chronic administration of nifedipine induces up-regulation of dihydropyridine receptors in rabbit heart. Am J Physiol 1994;267:H1222-6.
13. Spedding M, Paoletti R III. Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol Rev 1992;44:363-76.
14. Gaasch WH, Cole JS, Quinones MA, Alexander JK. Dynamic determinations of left ventricular diastolic pressure-volume relations in man. Circulation 1975;51:317-23.
15. Bradford MM. Rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
16. 3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazen. Biochem Biophys Res Commun 1982;108:110-7.
17. Gwathmey JK, Hajjar RJ, Solaro RJ Contractile deactivation and uncoupling of crossbridges. Circ Res 1991;69:1280-92.
18. Kentish JC, ter Keurs HEDJ, Ricciardi L, Bucx JJJ, Noble MIM. Comparison between the sarcomere length-force relations of intact and skinned trabeculae from rat right ventricle. Circ Res 1986;58:755-68.
19. Gengo P, Skattebol A, Moran JF, Gallant S, Hawthorn M, Triggle DJ. Regulation by chronic drug administration of neural and cardiac calcium channel, beta-adrenoceptor and muscarinic receptor level. Biochem Pharmacol 1988;37:627-33.
20. 3H]dihydroalprenolol binding sites. Eur J Pharmacol 1986;121:167-72.
21. Le Grand B, Hatem S, Deroubaix E, Couetil J-P, Coraboeuf E. Calcium current depression in isolated human atrial myocytes after cessation of chronic treatment with calcium antagonists. Circ Res 1991;69:292-300.
22. Lorell BH, Paulus WJ, Grossman W, Wynne J, Cohn PF. Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy. Circulation 1982;65:499-507.
23. Lorell BH, Turi Z, Grossman W. Modification of left ventricular response to pacing tachycardia by nifedipine in patients with coronary artery disease. Am J Physiol 1981;71:667-75.
24. Bonow RO. Effects of calcium-channel blocking agents on left ventricular diastolic function in hypertrophic cardiomyopathy and in coronary artery disease. Am J Cardiol 1985;55:172B-8B.
25. Kurnik PB, Courtois MR, Ludbrook PA. Effects of nifedipine on intrinsic myocardial stiffness in man. Circulation 1986;74:126-34.
26. Ludbrook PA, Tiefenbrunn AJ, Sobel BE. Influence of nifedipine on left ventricular systolic and diastolic function. Relationship to manifestations of ischemia and congestive heart failure. Am J Med 1981;71:683-92.
27. Mertsevich SY, Koutishenka N, Metelitsa VI. Withdrawal phenomenon after abrupt cessation of nifedipine in stable angina pectoris. Int J Cardiol 1993;42:298-301.
28. Frank JS, Langer GA. The myocardial interstition: its structure and its role in ionic exchange. J Cell Biol 1974;60:586-601.
29. 2+ regulation of vascular smooth muscle. Fed Proc 1986;45:2746-51.
30. Warltier DC, Zyvoloski MG, Groo GJ, Brooks HL. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade. J Pharmacol Exp Ther 1984;230:367-75.
31. Muiesan G, Agabiti-Rosei E, Castellano M, et al. Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension. J Cardiovasc Pharmacol 1982;4:S325-9.
32. Marsh JD. Co-regulation of calcium channels and beta adrenergic receptors in cultured chick embryo ventricular cells. J Clin Invest 1989;84:817-23.
33. Hescheler J, Kameyama M, Trautwein W, Mieskes G, Soling HD. Regulation of the cardiac calcium channel by protein phosphatases. Eur J Biochem 1987;165:261-6.
34. Franklin D, Millard RW, Nagao T. Responses of coronary collateral flow and dependent myocardial mechanical function to the calcium antagonist diltiazen. Chest 1980;78(suppl):200-4.
35. Gross R, Kirchhein H, Olshausen K. Effect of nifedipine on coronary and systemic hemodynamics in the conscious dog. Arzneimittel forschung 1979;29:1361-8.
36. Henry PD, Schuchleib R, Borda LJ, Roberts R, Williamson JR, Sobel BE. Effects of nifedipine on myocardial perfusion and ischemic injury in dogs. Circ Res 1978;43:372-80.